pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Health systems grapple with AI chatbot use, some block tools while others consider in-house solutions

Nov 5, 2026·read at STAT ↗RegulatoryNeutral

Free AI chatbots designed for clinicians, such as OpenEvidence, Doximity Ask and ChatGPT for Clinicians, have become popular, with hundreds of thousands of doctors turning to them for clinical guidance.

At Monument Health, a South Dakota and Wyoming health system, the chief information officer decided to block access to OpenEvidence after a doctor was found storing over a hundred patient records in the tool to aid decision‑making.

Health system leaders say the rapid adoption of these tools raises compliance and patient‑data‑privacy concerns, prompting some organizations to restrict use while others explore bringing AI capabilities in house.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: As more doctors consult chatbots, health systems can block them — or buy in”

read at STAT ↗
585 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Disc Medicine, Inc.
drugs
iron

related stories

  • 23h agoTop health takeaways from the midterm electionsSTAT
  • 1d agoSTAT+: Amid Mass General Brigham layoffs, CEO pens vague letter, stirring staff anxietySTAT
  • Oct 29Opinion: Health care needs buyers willing to say noSTAT
  • Sep 15Kairon Health raises $5M to use data to make patients healthierEndpoints
  • Sep 10A booming business on Wall Street would love more biotechs to quietly dieBioPharma Dive